Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

by Hiltsje Hepkema, Koen B Pouwels, Arie van der Ende, Tjalke A Westra, Maarten J Postma
Published 2013-01-01

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.

by Robin de Vries, Mirjam Kretzschmar, Joop F P Schellekens, Florens G A Versteegh, Tjalke A Westra, John J Roord, Maarten J Postma
Published 2010-01-01